ESTA - Establishment Labs Holdings Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Alajuela,
Costa Rica
Type: Equity
ESTA price evolution
ESTA
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $39.7 | $54.6 | $72.98 | $40.03 |
| Short term investments | ||||
| Net receivables | $67.64 | $59.98 | $50.84 | $46.92 |
| Inventory | $67.12 | $64.21 | $72.49 | $79.47 |
| Total current assets | $182.95 | $186.13 | $203.69 | $174.9 |
| Long term investments | ||||
| Property, plant & equipment | $84.27 | $83.26 | $83.15 | $80.59 |
| Goodwill & intangible assets | $10.51 | $9.98 | $8.45 | |
| Total noncurrent assets | $98.96 | $98.14 | $93.74 | |
| Total investments | ||||
| Total assets | $282.69 | $285.09 | $301.84 | $268.64 |
| Current liabilities | ||||
| Accounts payable | $34.4 | $28.42 | $31.07 | $41.62 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $50.5 | $41.89 | $48.02 | $57.15 |
| Long term debt | $194.36 | $196.72 | $195.37 | $191.45 |
| Total noncurrent liabilities | $198.18 | $196.91 | $193.1 | |
| Total debt | $196.72 | $195.37 | $191.45 | |
| Total liabilities | $249.97 | $240.07 | $244.93 | $250.25 |
| Shareholders' equity | ||||
| Retained earnings | -$410.16 | -$393.48 | -$376.3 | -$360.1 |
| Other shareholder equity | $3.23 | $3.12 | $2.08 | $1.96 |
| Total shareholder equity | $45.02 | $56.91 | $18.39 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $40.03 | $66.36 | $53.41 | $84.52 |
| Short term investments | ||||
| Net receivables | $46.92 | $36.82 | $24.44 | $19.13 |
| Inventory | $79.47 | $36.58 | $28.41 | $23.21 |
| Total current assets | $174.9 | $149.9 | $113.27 | $132.3 |
| Long term investments | ||||
| Property, plant & equipment | $80.59 | $54.79 | $20.86 | $18.81 |
| Goodwill & intangible assets | $8.45 | $5.07 | $4.84 | $4.61 |
| Total noncurrent assets | $93.74 | $61.16 | $26.26 | $24.09 |
| Total investments | ||||
| Total assets | $268.64 | $211.06 | $139.53 | $156.39 |
| Current liabilities | ||||
| Accounts payable | $41.62 | $20.03 | $14.47 | $9.72 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $57.15 | $38.96 | $31.89 | $25.9 |
| Long term debt | $191.45 | $175.46 | $53.81 | $51.76 |
| Total noncurrent liabilities | $193.1 | $180.29 | $56.9 | $55.53 |
| Total debt | $191.45 | $178.66 | $53.81 | $51.76 |
| Total liabilities | $250.25 | $219.25 | $88.79 | $81.43 |
| Shareholders' equity | ||||
| Retained earnings | -$360.1 | -$281.59 | -$206.38 | -$165.25 |
| Other shareholder equity | $1.96 | $2.71 | $3.66 | $2.87 |
| Total shareholder equity | $18.39 | -$8.19 | $50.74 | $74.96 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $44.12 | $37.17 | ||
| Cost of revenue | $15.18 | $12.79 | ||
| Gross Profit | $28.94 | $24.38 | ||
| Operating activities | ||||
| Research & development | $5.49 | $4.27 | ||
| Selling, general & administrative | $32.79 | $28.94 | ||
| Total operating expenses | $38.28 | $33.21 | ||
| Operating income | -$9.34 | -$8.83 | ||
| Income from continuing operations | ||||
| EBIT | -$11.57 | -$11.38 | ||
| Income tax expense | $0.43 | $0.44 | ||
| Interest expense | $5.19 | $4.38 | ||
| Net income | ||||
| Net income | -$17.18 | -$16.2 | ||
| Income (for common shares) | -$17.18 | -$16.2 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $165.15 | $161.7 | $126.68 | $84.68 |
| Cost of revenue | $58.17 | $55.1 | $41.28 | $32.17 |
| Gross Profit | $106.98 | $106.59 | $85.4 | $52.5 |
| Operating activities | ||||
| Research & development | $26.43 | $20.27 | $18.32 | $13.79 |
| Selling, general & administrative | $145.57 | $125.98 | $92.23 | $66.63 |
| Total operating expenses | $172 | $146.25 | $110.54 | $80.42 |
| Operating income | -$65.03 | -$39.66 | -$25.14 | -$27.92 |
| Income from continuing operations | ||||
| EBIT | -$63.19 | -$61.06 | -$30.65 | -$28.64 |
| Income tax expense | -$0.08 | $2.38 | $1.43 | $0.1 |
| Interest expense | $15.39 | $11.76 | $9.06 | $9.37 |
| Net income | ||||
| Net income | -$78.5 | -$75.21 | -$41.14 | -$38.12 |
| Income (for common shares) | -$78.5 | -$75.21 | -$41.14 | -$38.12 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$17.18 | -$16.2 | -$20.54 | |
| Operating activities | ||||
| Depreciation | $1.58 | $1.41 | $1.4 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.87 | $3.55 | $3.39 | |
| Total cash flows from operations | -$14.15 | -$11.15 | -$8.15 | |
| Investing activities | ||||
| Capital expenditures | -$1.53 | -$4.75 | -$3.66 | |
| Investments | ||||
| Total cash flows from investing | -$13.79 | -$4.4 | -$6.63 | -$4.62 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.58 | $51.16 | $0.1 | |
| Net borrowings | ||||
| Total cash flows from financing | $51.4 | $0.39 | $51.04 | $0.07 |
| Effect of exchange rate | -$0.18 | -$0.21 | -$0.32 | $0.55 |
| Change in cash and equivalents | -$0.34 | -$18.38 | $32.95 | -$12.15 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$78.5 | -$75.21 | -$41.14 | -$38.12 |
| Operating activities | ||||
| Depreciation | $4.88 | $4.34 | $4.12 | $3.71 |
| Business acquisitions & disposals | -$0.53 | -$0.43 | -$1.65 | |
| Stock-based compensation | $14.37 | $13.35 | $10.41 | $5.72 |
| Total cash flows from operations | -$88.51 | -$52.17 | -$27.53 | -$12.51 |
| Investing activities | ||||
| Capital expenditures | -$23.22 | -$32.77 | -$5.28 | -$2.42 |
| Investments | ||||
| Total cash flows from investing | -$24.55 | -$34.79 | -$7.16 | -$5.56 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $86.71 | $3.87 | $4.58 | $65.1 |
| Net borrowings | $96.39 | -$0.17 | -$0.28 | |
| Total cash flows from financing | $86.23 | $100.25 | $4.05 | $64.67 |
| Effect of exchange rate | $0.51 | -$0.36 | -$0.47 | $0.27 |
| Change in cash and equivalents | -$26.32 | $12.94 | -$31.11 | $46.87 |
News
Fundamentals
| Market cap | $965.32M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 27.96M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 1.42 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 13.60 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.62 |
| Quick ratio | 2.29 |